Unveiling Innovative Preclinical Meningeal Treg Research to Supercharge Therapeutic Development
Time: 1:45 pm
day: Focus Day
Details:
- Exploring the Treg population in the meninges in mouse and humans
- Navigating Treg tolerogenic mechanism in the meninges
- Discussing Treg/INF-γ regulation (inflammation)
- Evaluating Treg/B-cells and plasma cell control
- Discovering how meningeal Tregs change in neurodegenerative diseases (AD) in mouse and human
